BrightSpire Capital股票讨论区

$BrightSpire Capital(BRSP.US)$2018年上市，是做地产债务投资的，近5年来有4年都在大幅亏损，仅有2022年盈利，但是2023年上半年又开始亏损。
目前市盈率19.6，市盈率TTM亏损，市净率0.66，股息率12%，看起来风险过高。

Gapping up
In reaction to earnings/guidance:
$RPM International(RPM.US)$ +2.4%
Other news:
$Radiant Logistics(RLGT.US)$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US)$ +3.3% (declares Q4 dividends of $0.34 per share)
$金海洋集团(GOGL.US)$ +2.5% (authorizes new $100 mln share repurchase program)
$iPATH 标普500 VIX短期期货ETN(VXX.US)$ +1.5% (rising with pull back in stock futures)
$Pebblebrook Hotel Trust(PEB.US)$ +1.3% (se...

Gainers:
• $Akero Therapeutics(AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital(BRSP.US)$ +6.3% (increases dividend)
• $Humanigen(HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $艾里逊变速箱(ALSN.US)$ +2.8% (electric hybrid bu...